Osteoid osteoma is a benign osteoid-producing bone tumor smaller than 2 cm. It typically occurs in young males aged 5-30 years (M:F = 2-3:1). It most commonly involves the diaphysis/metaphysis of the femur and tibia, and posterior vertebral elements. The characteristic clinical finding is night pain with dramatic relief from NSAIDs (aspirin, ibuprofen) — this clinical feature is diagnostically specific. Radiologically, a small nidus (<2cm) surrounded by prominent reactive sclerosis is seen. Thin-section CT is the gold standard for nidus evaluation. Treatment includes CT-guided radiofrequency ablation (RFA) or surgical excision. It does not undergo malignant transformation.
Age Range
5-30
Peak Age
15
Gender
Male predominant
Prevalence
Common
Osteoid osteoma is a benign neoplastic process developing around a small nidus with high osteoblastic activity. The nidus consists of vascularized osteoid tissue and immature woven bone trabeculae; surrounded by a reactive sclerosis ring. Osteoblasts within the nidus produce high amounts of prostaglandin (PGE2) and cyclooxygenase-2 (COX-2) — these mediators create both pain and reactive vasodilation and edema in surrounding bone. Dramatic pain relief through COX-2 inhibition by NSAIDs confirms this pathophysiological mechanism. Radiologically, the high vascularity of the nidus manifests as central calcification on CT and enhancement on MRI. Surrounding reactive sclerosis represents periosteal and endosteal new bone formation — appearing as dense sclerotic ring on CT and low T1/T2 signal on MRI. Intra-articular lesions may develop reactive synovitis and joint effusion.
Central calcification (punctate or ring-shaped) within a <2cm nidus and prominent surrounding reactive sclerosis ring on thin-section CT — pathognomonic for osteoid osteoma. Diagnosis is confirmed when combined with clinical night pain and NSAID response. Thin-section (≤1mm) CT is mandatory due to the small nidus size; otherwise the nidus is obscured within dense sclerosis.
Pathognomonic finding of osteoid osteoma on thin-section (≤1mm) CT: a well-defined, round or oval nidus (<2cm, usually <1.5cm) containing central punctate or ring-shaped calcification. Prominent reactive sclerosis ring surrounds the nidus — this sclerosis may be many times larger than the nidus itself. The nidus is usually intracortical (most common) but medullary, subperiosteal, or intra-articular locations may also occur. Thin-section CT is the gold standard for nidus evaluation — on thick sections, the nidus may be obscured within dense sclerosis. Cortical thickening and fusiform bone expansion may accompany.
Report Sentence
An intracortical nidus measuring approximately ___ mm with central calcification is seen in the [location] of the [bone], surrounded by prominent reactive sclerosis; consistent with osteoid osteoma.
On contrast-enhanced CT, the nidus shows prominent enhancement — reflecting its high vascularity. Enhancement delineates the nidus boundaries more clearly and facilitates differentiation from surrounding sclerosis. Central calcification appears as a non-enhancing dense focus. Surrounding reactive sclerosis does not enhance. Early arterial enhancement may be seen on dynamic CT (perfusion). This enhancement pattern is helpful for nidus localization before RFA.
Report Sentence
On contrast-enhanced CT, the nidus shows prominent enhancement, with central calcification seen as a non-enhancing focus; no enhancement identified in the surrounding reactive sclerosis.
On T1-weighted sequences, the nidus demonstrates low to intermediate signal intensity. Central calcification appears as a very low signal focus. Surrounding reactive sclerosis shows low signal (mineralized bone). The notable finding is disproportionately wide bone marrow changes around the nidus — low T1 signal areas reflecting surrounding edema and vascular congestion. This extensive edema represents the inflammatory response caused by the small nidus. Intra-articular lesions may be accompanied by synovial thickening and effusion.
Report Sentence
On T1-weighted sequences, the nidus demonstrates low signal intensity with disproportionately extensive surrounding bone marrow signal changes (edema).
On T2-weighted sequences, the nidus shows variable signal — ranging from low to high depending on the degree of mineralization. Calcified nidus gives low signal, non-calcified nidus gives high signal. The most striking finding is prominent high T2 signal bone marrow and soft tissue edema surrounding the nidus. This edema zone is much larger than the nidus (5-10 times the nidus size) and may confuse the diagnosis — especially when the small nidus is hidden within edema. Intra-articular lesions are accompanied by joint effusion and synovial enhancement.
Report Sentence
On T2-weighted sequences, the nidus demonstrates [low/intermediate/high] signal intensity with disproportionately extensive surrounding bone marrow and soft tissue edema.
On STIR, surrounding bone marrow edema is seen as markedly high signal. Fat suppression optimizes edema-marrow contrast better than T2. The nidus can be identified as a focal low or intermediate signal focus within the edema area. STIR's high sensitivity for edema detection is useful in cases with clinical suspicion but negative conventional imaging. The boundaries of the edema zone that may extend along the entire bone are best evaluated on STIR.
Report Sentence
On STIR, extensive bone marrow edema is seen, with the focal nidus focus [identifiable/not identifiable] within the edema area; CT correlation is recommended.
On post-gadolinium T1-weighted sequences, the nidus shows prominent enhancement — reflecting its high vascularity. Enhancement facilitates nidus identification within the edema. Fat-suppressed post-contrast T1 (T1 FS post-Gd) is the best sequence for nidus visualization. Surrounding bone marrow and soft tissue may show inflammatory enhancement. Intra-articular lesions show prominent synovial enhancement. Reactive sclerosis does not enhance.
Report Sentence
On fat-suppressed post-contrast sequences, the nidus shows prominent enhancement, accompanied by surrounding bone marrow and soft tissue inflammatory enhancement changes.
On diffusion-weighted imaging, the nidus may show variable diffusion restriction — depending on cellularity and vascularity. Surrounding bone marrow edema does not show restricted diffusion (T2 shine-through artifact may occur — should be confirmed with ADC map). DWI is not the primary modality for osteoid osteoma diagnosis and plays a supportive role in differentiating from malignant lesions. Malignant tumors like Ewing sarcoma or osteosarcoma show prominent diffusion restriction, while the edema zone in osteoid osteoma generally shows high ADC values.
Report Sentence
On diffusion-weighted imaging, surrounding bone marrow edema shows no restricted diffusion, with [variable/mild] diffusion restriction noted in the nidus region.
Criteria
Located within the cortex (most common type, 75%); prominent reactive sclerosis and cortical thickening, nidus embedded within cortex
Distinct Features
Classic radiological appearance — nidus embedded in dense sclerotic cortex. Thin-section CT is mandatory for nidus identification. Fusiform cortical thickening accompanies. Nidus may be difficult to identify on MRI due to sclerosis — CT is the gold standard.
Criteria
Located within the medullary cavity (20%); reactive sclerosis less prominent, nidus more easily identified
Distinct Features
Less reactive sclerosis compared to intracortical type. Nidus is more visible on CT as a low-density area within the medullary cavity. Surrounding edema on MRI can be very prominent and may mimic a tumor. Nidus enhancement is critical for diagnosis.
Criteria
Located within the joint capsule (5-10%); most commonly hip joint (femoral neck); minimal reactive sclerosis, joint effusion and synovitis dominant
Distinct Features
Reactive sclerosis is usually minimal — classic appearance is absent. Dominant findings are joint effusion, synovial thickening, and osteoporosis (immobilization). Diagnostic delay is common — confused with juvenile arthritis or septic arthritis. Thin-section CT is essential for nidus identification. Synovial enhancement and effusion are prominent on MRI.
Distinguishing Feature
Osteoblastoma has nidus size >2cm (osteoid osteoma <2cm); less prominent reactive sclerosis, more expansile and aggressive appearance. Osteoblastoma is more common and larger in posterior vertebral elements. Clinically, NSAID response is less pronounced in osteoblastoma.
Distinguishing Feature
Osteomyelitis also shows bone marrow edema and enhancement but Brodie's abscess shows intracortical channels (cloaca, sinus tract) and periosteal reaction (lamellar type). In osteoid osteoma, the nidus has a regular round/oval shape; in osteomyelitis, the abscess cavity has more irregular margins. Abscess shows restricted diffusion on DWI.
Distinguishing Feature
Ewing sarcoma shows aggressive permeative bone destruction, large soft tissue mass, lamellar ('onion-skin') periosteal reaction, and prominent diffusion restriction. Osteoid osteoma has no soft tissue mass, periosteal reaction is benign type or absent. Although the age group is similar, clinical presentation (night pain + NSAID response) is different.
Distinguishing Feature
Osteosarcoma shows aggressive osteoid matrix production (sunburst, cloud-like calcification), wide transition zone, soft tissue mass, and Codman triangle. In osteoid osteoma, matrix production is limited to the nidus (<2cm), transition zone is narrow, and no soft tissue component. Size distinction is critical: <2cm = osteoid osteoma, >2cm = osteoblastoma, aggressive features = osteosarcoma.
Urgency
lowManagement
CT-guided radiofrequency ablation (RFA) is first-line treatment; surgical en-bloc excision for RFA-inaccessible or recurrent lesions; NSAID therapy for pain management while awaiting treatmentBiopsy
Not NeededFollow-up
Post-RFA CT at 6 months and 1 year to confirm ablation; clinical follow-up for symptom recurrence; recurrence rate <5% after successful RFAOsteoid osteoma is a benign tumor that does not undergo malignant transformation. NSAID therapy provides symptomatic relief but is not curative. CT-guided radiofrequency ablation (RFA) is first-line treatment — 90-95% success rate, minimally invasive, short recovery time. In RFA, a probe is placed within the nidus and heated to 90°C to create thermal necrosis. Surgical en-bloc excision is applied for RFA-inaccessible lesions (near spinal cord, intra-articular) or recurrent cases. Biopsy is not routine — diagnosis is made with typical clinical and radiological findings. Spontaneous regression may occur over years in untreated cases but prognosis is uncertain.
Osteoid osteoma is a benign tumor with no malignant transformation risk. Treatment options: radiofrequency ablation (RFA — gold standard, 90%+ success), surgical resection, or conservative (long-term NSAIDs). Spontaneous regression is possible but may take years.